Generics Global Group of Eight (G8) Industry Guide 2017-2021

Generics Global Group of Eight (G8) Industry Guide 2017-2021

Table of Contents
Introduction 14
What is this report about? 14
Who is the target reader? 14
How to use this report 14
Definitions 14
Group of Eight (G8) Generics 15
Industry Outlook 15
Generics in Canada 19
Market Overview 19
Market Data 20
Market Segmentation 22
Market outlook 23
Five forces analysis 25
Macroeconomic indicators 31
Generics in France 33
Market Overview 33
Market Data 34
Market Segmentation 36
Market outlook 37
Five forces analysis 39
Macroeconomic indicators 45
Generics in Germany 47
Market Overview 47
Market Data 48
Market Segmentation 50
Market outlook 51
Five forces analysis 53
Macroeconomic indicators 59
Generics in Italy 61
Market Overview 61
Market Data 62
Market Segmentation 64
Market outlook 65
Five forces analysis 67
Macroeconomic indicators 73
Generics in Japan 75
Market Overview 75
Market Data 76
Market Segmentation 78
Market outlook 79
Five forces analysis 81
Macroeconomic indicators 87
Generics in Russia 89
Market Overview 89
Market Data 90
Market Segmentation 92
Market outlook 93
Five forces analysis 95
Macroeconomic indicators 101
Generics in The United Kingdom 103
Market Overview 103
Market Data 104
Market Segmentation 106
Market outlook 107
Five forces analysis 109
Macroeconomic indicators 115
Generics in The United States 117
Market Overview 117
Market Data 118
Market Segmentation 120
Market outlook 121
Five forces analysis 123
Macroeconomic indicators 129
Company Profiles 131
Leading Companies 131
Appendix 161
Methodology 161
About MarketLine 162

List of Tables
Table 1: G8 generics industry, revenue($m), 2012-21
Table 2: G8 generics industry, revenue by country ($m), 2012-16
Table 3: G8 generics industry forecast, revenue by country ($m), 2016-21
Table 4: Canada generics market value: $ million, 2012-16
Table 5: Canada generics market volume: % of total pharma volume, 2012-16
Table 6: Canada generics market geography segmentation: $ million, 2016
Table 7: Canada generics market value forecast: $ million, 2016-21
Table 8: Canada generics market volume forecast: % of total pharma volume, 2016-21
Table 87: Canada size of population (million), 2012-16
Table 88: Canada gdp (constant 2005 prices, $ billion), 2012-16
Table 89: Canada gdp (current prices, $ billion), 2012-16
Table 90: Canada inflation, 2012-16
Table 91: Canada consumer price index (absolute), 2012-16
Table 92: Canada exchange rate, 2012-16
Table 9: France generics market value: $ million, 2012-16
Table 10: France generics market volume: % of total pharma volume, 2012-16
Table 11: France generics market geography segmentation: $ million, 2016
Table 12: France generics market value forecast: $ million, 2016-21
Table 13: France generics market volume forecast: % of total pharma volume, 2016-21
Table 14: France size of population (million), 2012-16
Table 15: France gdp (constant 2005 prices, $ billion), 2012-16
Table 16: France gdp (current prices, $ billion), 2012-16
Table 17: France inflation, 2012-16
Table 18: France consumer price index (absolute), 2012-16
Table 19: France exchange rate, 2012-16
Table 20: Germany generics market value: $ million, 2012-16
Table 21: Germany generics market volume: % of total pharma volume, 2012-16
Table 22: Germany generics market geography segmentation: $ million, 2016
Table 23: Germany generics market value forecast: $ million, 2016-21
Table 24: Germany generics market volume forecast: % of total pharma volume, 2016-21
Table 25: Germany size of population (million), 2012-16
Table 26: Germany gdp (constant 2005 prices, $ billion), 2012-16
Table 27: Germany gdp (current prices, $ billion), 2012-16
Table 28: Germany inflation, 2012-16
Table 29: Germany consumer price index (absolute), 2012-16
Table 30: Germany exchange rate, 2012-16
Table 31: Italy generics market value: $ million, 2012-16
Table 32: Italy generics market volume: % of total pharma volume, 2012-16
Table 33: Italy generics market geography segmentation: $ million, 2016
Table 34: Italy generics market value forecast: $ million, 2016-21
Table 35: Italy generics market volume forecast: % of total pharma volume, 2016-21
Table 36: Italy size of population (million), 2012-16
Table 37: Italy gdp (constant 2005 prices, $ billion), 2012-16
Table 38: Italy gdp (current prices, $ billion), 2012-16
Table 39: Italy inflation, 2012-16
Table 40: Italy consumer price index (absolute), 2012-16
Table 41: Italy exchange rate, 2012-16
Table 42: Japan generics market value: $ billion, 2012-16
Table 43: Japan generics market volume: % of total pharma volume, 2012-16
Table 44: Japan generics market geography segmentation: $ billion, 2016
Table 45: Japan generics market value forecast: $ billion, 2016-21
Table 46: Japan generics market volume forecast: % of total pharma volume, 2016-21
Table 47: Japan size of population (million), 2012-16
Table 48: Japan gdp (constant 2005 prices, $ billion), 2012-16
Table 49: Japan gdp (current prices, $ billion), 2012-16
Table 50: Japan inflation, 2012-16
Table 51: Japan consumer price index (absolute), 2012-16
Table 52: Japan exchange rate, 2012-16
Table 53: Russia generics market value: $ million, 2012-16
Table 54: Russia generics market volume: % of total pharma volume, 2012-16
Table 55: Russia generics market geography segmentation: $ million, 2016
Table 56: Russia generics market value forecast: $ million, 2016-21
Table 57: Russia generics market volume forecast: % of total pharma volume, 2016-21
Table 58: Russia size of population (million), 2012-16
Table 59: Russia gdp (constant 2005 prices, $ billion), 2012-16
Table 60: Russia gdp (current prices, $ billion), 2012-16
Table 61: Russia inflation, 2012-16
Table 62: Russia consumer price index (absolute), 2012-16
Table 63: Russia exchange rate, 2012-16
Table 64: United Kingdom generics market value: $ million, 2012-16
Table 65: United Kingdom generics market volume: % of total pharma volume, 2012-16
Table 66: United Kingdom generics market geography segmentation: $ million, 2016
Table 67: United Kingdom generics market value forecast: $ million, 2016-21
Table 68: United Kingdom generics market volume forecast: % of total pharma volume, 2016-21
Table 69: United Kingdom size of population (million), 2012-16
Table 70: United Kingdom gdp (constant 2005 prices, $ billion), 2012-16
Table 71: United Kingdom gdp (current prices, $ billion), 2012-16
Table 72: United Kingdom inflation, 2012-16
Table 73: United Kingdom consumer price index (absolute), 2012-16
Table 74: United Kingdom exchange rate, 2012-16
Table 75: United States generics market value: $ billion, 2012-16
Table 76: United States generics market volume: % of total pharma volume, 2012-16
Table 77: United States generics market geography segmentation: $ billion, 2016
Table 78: United States generics market value forecast: $ billion, 2016-21
Table 79: United States generics market volume forecast: % of total pharma volume, 2016-21
Table 80: United States size of population (million), 2012-16
Table 81: United States gdp (constant 2005 prices, $ billion), 2012-16
Table 82: United States gdp (current prices, $ billion), 2012-16
Table 83: United States inflation, 2012-16
Table 84: United States consumer price index (absolute), 2012-16
Table 85: United States exchange rate, 2012-15
Table 86: Apotex, Inc.: key facts
Table 93: Les Laboratoires Servier: key facts
Table 94: STADA Arzneimittel AG: key facts
Table 95: STADA Arzneimittel AG: key financials ($)
Table 96: STADA Arzneimittel AG: key financials (€)
Table 97: STADA Arzneimittel AG: key financial ratios
Table 98: Sanofi SA: key facts
Table 99: Sanofi SA: key financials ($)
Table 100: Sanofi SA: key financials (€)
Table 101: Sanofi SA: key financial ratios
Table 102: Sawai Pharmaceutical Co., Ltd.: key facts
Table 103: Sawai Pharmaceutical Co., Ltd.: key financials ($)
Table 104: Sawai Pharmaceutical Co., Ltd.: key financials (¥)
Table 105: Sawai Pharmaceutical Co., Ltd.: key financial ratios
Table 106: Daiichi Sankyo Co., Ltd.: key facts
Table 107: Daiichi Sankyo Co., Ltd.: key financials ($)
Table 108: Daiichi Sankyo Co., Ltd.: key financials (¥)
Table 109: Daiichi Sankyo Co., Ltd.: key financial ratios
Table 110: Abbott Laboratories: key facts
Table 111: Abbott Laboratories: key financials ($)
Table 112: Abbott Laboratories: key financial ratios
Table 113: Krka, d. d., Novo mesto: key facts
Table 114: Krka, d. d., Novo mesto: key financials ($)
Table 115: Krka, d. d., Novo mesto: key financials (€)
Table 116: Krka, d. d., Novo mesto: key financial ratios
Table 117: Mylan N.V.: key facts
Table 118: Mylan N.V.: key financials ($)
Table 119: Mylan N.V.: key financial ratios
Table 120: Novartis AG: key facts
Table 121: Novartis AG: key financials ($)
Table 122: Novartis AG: key financial ratios
Table 123: Teva Pharmaceutical Industries Limited: key facts
Table 124: Teva Pharmaceutical Industries Limited: key financials ($)
Table 125: Teva Pharmaceutical Industries Limited: key financial ratios

List of Figures
Figure 1: G8 generics industry, revenue($m), 2012-21
Figure 2: G8 Generics industry, revenue by country (%), 2016
Figure 3: G8 generics industry, revenue by country ($m), 2012-16
Figure 4: G8 generics industry forecast, revenue by country ($m), 2016-21
Figure 5: Canada generics market value: $ million, 2012-16
Figure 6: Canada generics market volume: % of total pharma volume, 2012-16
Figure 7: Canada generics market geography segmentation: % share, by value, 2016
Figure 8: Canada generics market value forecast: $ million, 2016-21
Figure 9: Canada generics market volume forecast: % of total pharma volume, 2016-21
Figure 10: Forces driving competition in the generics market in Canada, 2016
Figure 11: Drivers of buyer power in the generics market in Canada, 2016
Figure 12: Drivers of supplier power in the generics market in Canada, 2016
Figure 13: Factors influencing the likelihood of new entrants in the generics market in Canada, 2016
Figure 14: Factors influencing the threat of substitutes in the generics market in Canada, 2016
Figure 15: Drivers of degree of rivalry in the generics market in Canada, 2016
Figure 16: France generics market value: $ million, 2012-16
Figure 17: France generics market volume: % of total pharma volume, 2012-16
Figure 18: France generics market geography segmentation: % share, by value, 2016
Figure 19: France generics market value forecast: $ million, 2016-21
Figure 20: France generics market volume forecast: % of total pharma volume, 2016-21
Figure 21: Forces driving competition in the generics market in France, 2016
Figure 22: Drivers of buyer power in the generics market in France, 2016
Figure 23: Drivers of supplier power in the generics market in France, 2016
Figure 24: Factors influencing the likelihood of new entrants in the generics market in France, 2016
Figure 25: Factors influencing the threat of substitutes in the generics market in France, 2016
Figure 26: Drivers of degree of rivalry in the generics market in France, 2016
Figure 27: Germany generics market value: $ million, 2012-16
Figure 28: Germany generics market volume: % of total pharma volume, 2012-16
Figure 29: Germany generics market geography segmentation: % share, by value, 2016
Figure 30: Germany generics market value forecast: $ million, 2016-21
Figure 31: Germany generics market volume forecast: % of total pharma volume, 2016-21
Figure 32: Forces driving competition in the generics market in Germany, 2016
Figure 33: Drivers of buyer power in the generics market in Germany, 2016
Figure 34: Drivers of supplier power in the generics market in Germany, 2016
Figure 35: Factors influencing the likelihood of new entrants in the generics market in Germany, 2016
Figure 36: Factors influencing the threat of substitutes in the generics market in Germany, 2016
Figure 37: Drivers of degree of rivalry in the generics market in Germany, 2016
Figure 38: Italy generics market value: $ million, 2012-16
Figure 39: Italy generics market volume: % of total pharma volume, 2012-16
Figure 40: Italy generics market geography segmentation: % share, by value, 2016
Figure 41: Italy generics market value forecast: $ million, 2016-21
Figure 42: Italy generics market volume forecast: % of total pharma volume, 2016-21
Figure 43: Forces driving competition in the generics market in Italy, 2016
Figure 44: Drivers of buyer power in the generics market in Italy, 2016
Figure 45: Drivers of supplier power in the generics market in Italy, 2016
Figure 46: Factors influencing the likelihood of new entrants in the generics market in Italy, 2016
Figure 47: Factors influencing the threat of substitutes in the generics market in Italy, 2016
Figure 48: Drivers of degree of rivalry in the generics market in Italy, 2016
Figure 49: Japan generics market value: $ billion, 2012-16
Figure 50: Japan generics market volume: % of total pharma volume, 2012-16
Figure 51: Japan generics market geography segmentation: % share, by value, 2016
Figure 52: Japan generics market value forecast: $ billion, 2016-21
Figure 53: Japan generics market volume forecast: % of total pharma volume, 2016-21
Figure 54: Forces driving competition in the generics market in Japan, 2016
Figure 55: Drivers of buyer power in the generics market in Japan, 2016
Figure 56: Drivers of supplier power in the generics market in Japan, 2016
Figure 57: Factors influencing the likelihood of new entrants in the generics market in Japan, 2016
Figure 58: Factors influencing the threat of substitutes in the generics market in Japan, 2016
Figure 59: Drivers of degree of rivalry in the generics market in Japan, 2016
Figure 60: Russia generics market value: $ million, 2012-16
Figure 61: Russia generics market volume: % of total pharma volume, 2012-16
Figure 62: Russia generics market geography segmentation: % share, by value, 2016
Figure 63: Russia generics market value forecast: $ million, 2016-21
Figure 64: Russia generics market volume forecast: % of total pharma volume, 2016-21
Figure 65: Forces driving competition in the generics market in Russia, 2016
Figure 66: Drivers of buyer power in the generics market in Russia, 2016
Figure 67: Drivers of supplier power in the generics market in Russia, 2016
Figure 68: Factors influencing the likelihood of new entrants in the generics market in Russia, 2016
Figure 69: Factors influencing the threat of substitutes in the generics market in Russia, 2016
Figure 70: Drivers of degree of rivalry in the generics market in Russia, 2016
Figure 71: United Kingdom generics market value: $ million, 2012-16
Figure 72: United Kingdom generics market volume: % of total pharma volume, 2012-16
Figure 73: United Kingdom generics market geography segmentation: % share, by value, 2016
Figure 74: United Kingdom generics market value forecast: $ million, 2016-21
Figure 75: United Kingdom generics market volume forecast: % of total pharma volume, 2016-21
Figure 76: Forces driving competition in the generics market in the United Kingdom, 2016
Figure 77: Drivers of buyer power in the generics market in the United Kingdom, 2016
Figure 78: Drivers of supplier power in the generics market in the United Kingdom, 2016
Figure 79: Factors influencing the likelihood of new entrants in the generics market in the United Kingdom, 2016
Figure 80: Factors influencing the threat of substitutes in the generics market in the United Kingdom, 2016
Figure 81: Drivers of degree of rivalry in the generics market in the United Kingdom, 2016
Figure 82: United States generics market value: $ billion, 2012-16
Figure 83: United States generics market volume: % of total pharma volume, 2012-16
Figure 84: United States generics market geography segmentation: % share, by value, 2016
Figure 85: United States generics market value forecast: $ billion, 2016-21
Figure 86: United States generics market volume forecast: % of total pharma volume, 2016-21
Figure 87: Forces driving competition in the generics market in the United States, 2016
Figure 88: Drivers of buyer power in the generics market in the United States, 2016
Figure 89: Drivers of supplier power in the generics market in the United States, 2016
Figure 90: Factors influencing the likelihood of new entrants in the generics market in the United States, 2016
Figure 91: Factors influencing the threat of substitutes in the generics market in the United States, 2016
Figure 92: Drivers of degree of rivalry in the generics market in the United States, 2016
Figure 93: STADA Arzneimittel AG: revenues & profitability
Figure 94: STADA Arzneimittel AG: assets & liabilities
Figure 95: Sanofi SA: revenues & profitability
Figure 96: Sanofi SA: assets & liabilities
Figure 97: Sawai Pharmaceutical Co., Ltd.: revenues & profitability
Figure 98: Sawai Pharmaceutical Co., Ltd.: assets & liabilities
Figure 99: Daiichi Sankyo Co., Ltd.: revenues & profitability
Figure 100: Daiichi Sankyo Co., Ltd.: assets & liabilities
Figure 101: Abbott Laboratories: revenues & profitability
Figure 102: Abbott Laboratories: assets & liabilities
Figure 103: Krka, d. d., Novo mesto: revenues & profitability
Figure 104: Krka, d. d., Novo mesto: assets & liabilities
Figure 105: Mylan N.V.: revenues & profitability
Figure 106: Mylan N.V.: assets & liabilities
Figure 107: Novartis AG: revenues & profitability
Figure 108: Novartis AG: assets & liabilities
Figure 109: Teva Pharmaceutical Industries Limited: revenues & profitability
Figure 110: Teva Pharmaceutical Industries Limited: assets & liabilities

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs